Deep Braining...
TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

Nektar Therapeutics (NKTR)
Nektar Therapeutics
XNAS:NKTR
55.93
-8.48%

Ask
$56.00 - 900.00
Bid
$55.14 - 100.00
Low
$54.66
High
$61.11
Open
$61.11
Prev Close
$61.11
52W High
66.92
52W Low
6.48
Volume
663504
Avg Vol (3m)
633518.7
Float
20048660.62
Chart
TendieTensor AI Analysis

Company
Asset Type: Common Stock
SIC Code: 2834
Sector: Health Technology
Industry: Pharmaceuticals: Major
Date Listed: 05/03/1994
Primary Exchange: XNAS

Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.

Phone: (415) 482-5300
Address: 455 Mission Bay Boulevard South
City: San Francisco
State: CA
Postal Code: 94158
TendieTensor AI Analyst Recommendation:
Fundamentals
Total Employees:
61
P/E (TTM)
-7.700000
P/B (TTM)
14.114700
EPS
-1.87
Round Lot
100
Composit FIGI
BBG000BHCYJ1
Share Class FIGI
BBG001S7RDK1
Share Class Shares Outstanding
19.02M
Weighted Shares Outstanding
19.02M

Technicals
RSI (14)
MACD Line
MACD Signal
SMA 20
SMA 50
EMA 50
Trend
Short Interest
Days to Cover
Higher = harder to cover
Short Interest Δ
Prev: —
Short Volume Ratio (Today)
5D avg:
Squeeze Score (0–100)
Discussion
Login to participate in discussions.
Recent News
Related Stocks

Based on the portfolios of people who own NKTR. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.